ALVO

ALVO

USD

Alvotech Ordinary Shares

$4.830-0.260 (-5.108%)

Prix en Temps Réel

Healthcare
Drug Manufacturers - Specialty & Generic
Luxembourg

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$5.090

Haut

$5.100

Bas

$4.700

Volume

0.89M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.5B

Industrie

Drug Manufacturers - Specialty & Generic

Pays

Luxembourg

Statistiques de Trading

Volume Moyen

0.47M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $4.7Actuel $4.830Haut $13.7

Actualités Connexes

GlobeNewswire

Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Alvotech ("Alvotech" or the "Company") (NASDAQ:ALVO). The investigation concerns whether the

Voir plus
Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)
Analyst Upgrades

Deutsche Bank Downgrades Alvotech to Hold, Lowers Price Target to $8

Deutsche Bank analyst Niall Alexander downgrades Alvotech from Buy to Hold and lowers the price target from $14 to $8.

Voir plus
Deutsche Bank Downgrades Alvotech to Hold, Lowers Price Target to $8
GlobeNewswire

Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05

REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today

Voir plus
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
GlobeNewswire

Alvotech Announces Changes in Global Business Development and Commercial Operations Team

REYKJAVIK, Iceland, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced

Voir plus
Alvotech Announces Changes in Global Business Development and Commercial Operations Team